Sex differences | 28 day survival differences | ||||||
---|---|---|---|---|---|---|---|
Men (n=2159) | Women (n=447) | p | Deceased (n=284) | Survivors (n=2322) | p | ||
Age:mean (SD) | 59.4 (10.1) | 65.0 (8.2) | <0.001 | 65.4 (7.7) | 59.7 (10.1) | <0.001 | |
Sex (% women) | — | — | — | 29.6 | 15.6 | <0.001 | |
Hypertension (%) | 40.3 | 61.2 | <0.001 | 54.2 | 42.7 | <0.001 | |
Diabetes (%) | 18.4 | 45.9 | <0.001 | 30.3 | 22.3 | 0.04 | |
Current smokers (%) | 66.2 | 7.5 | <0.001 | 41.6 | 58.4 | <0.001 | |
Angina (%) | 46.8 | 51.3 | 0.09 | 50.2 | 47.2 | 0.48 | |
History of cardiac failure (%)1-151 | 8.0 | 19.4 | <0.001 | 27.0 | 8.4 | <0.001 | |
Clinical characteristics of acute event and interventions | |||||||
Anterior myocardial infarction (%) | 45.8 | 53.0 | 0.008 | 65.2 | 44.9 | <0.001 | |
APE/cardiogenic shock (%) | 10.8 | 25.4 | <0.001 | 61.8 | 7.5 | <0.001 | |
Severe arrhythmia (%)1-150 | 15.3 | 14.4 | 0.69 | 36.3 | 12.5 | <0.001 | |
Thrombolysis (%)1-152 | 42.2 | 23.9 | <0.001 | 15.9 | 41.1 | <0.001 | |
Antiplatelet drugs (%)1-152 | 86.9 | 85.8 | 0.39 | 66.9 | 88.6 | <0.001 | |
28 day coronary angiograms (%) | 6.6 | 7.2 | 0.70 | 3.5 | 7.1 | 0.03 | |
28 day revascularisation (%)1-153 | 2.1 | 2.7 | 0.54 | 2.7 | 2.1 | 0.7 | |
28 day mortality (%) | 9.3 | 18.8 | <0.001 | — | — | — |
APE = acute pulmonary oedema.
↵1-150 Ventricular fibrillation or tachycardia requiring immediate medical intervention.
↵1-151 Only 1988–1997.
↵1-152 In patients admitted from 1988 to 1997 after introduction of routine antiplatelet drugs and thrombolysis.
↵1-153 Percutaneous transluminal coronary angioplasty or coronary artery bypass surgery.